Cerner’s president leaves for Trizetto

  • 15 July 2010

The president of Cerner Corporation is to leave the company and take up a new position as the chief executive of Trizetto Solutions.

Trace Devanney had been due to relocate to London this summer to head up Cerner’s international operations and expansion.

Devanny’s responsibilities will be taken on by the current top management. Long term Cerner chairman and chief executive Neal Patterson will now also take on the title of president.

Trace is a highly experienced and growth-focused leader,” said TriZetto founder and chairman Jeff Margolis. Trizetto focuses on integrated care management with a strong position in the US, plus international clients.

“Having been part of a leadership team that enjoyed tremendous growth at Cerner, I look forward to helping TriZetto capitalize on the many new growth opportunities it has created,” Devanny said ina statement.

Devanny joined Cerner in 1994 and has been the president of Cerner since 1999, a period during which Kansas City based health It company has enjoyed remarkable growth.

During his tenure the company Devanny led the company’s five-fold expansion in revenue, including creating the company’s global presence and brand.

Subscribe to our newsletter

Subscribe To Our Newsletter

Subscribe To Our Newsletter

Sign up

Related News

GPs to get easier access to Yorkshire and Humber Care Record

GPs to get easier access to Yorkshire and Humber Care Record

The first GP practice has gone live with an EMIS functionality which allows easier access to the Yorkshire and Humber Care Record.
OneLondon’s UCP expands to sickle cell disease patients

OneLondon’s UCP expands to sickle cell disease patients

The Universal Care Plan (UCP), OneLondon’s shared care planning solution, has extended to support sickle cell disease patients.
NHS clinical scientist warns of AI ‘deployment blockage’

NHS clinical scientist warns of AI ‘deployment blockage’

A "deployment blockage" in the NHS is preventing AI from being adopted at scale, according to an NHS consultant clinical scientist.